Key aspects of modern drug discovery 2023
6-7 November 2023
Novotel Leeds City Centre

Early booking deadlines: 6 September 2023. Limited places available - book now to avoid disappointment.

 Register now

Designed and delivered by experts from industry and academia, this training event will provide a comprehensive overview of the pre-clinical drug discovery process. The workshop will focus on small molecule target identification and validation, hit-to-lead and lead optimisation, as well as on pre-clinical drug development and toxicology. The programme will include lectures, case studies and small group discussions, and will provide an opportunity for delegates to engage with speakers.

Programme Coordinators for this event are:

  • Augustin Amour, GSK
  • Rick Davies, AstraZeneca
  • Dmitra Mitsa, University of Leeds
  • Dominic Tisi, Astex
  • John Unitt, Sygnature Discovery

Invited speakers for this event are:

  • Andy Davies, AstraZeneca
  • Stephanie Gresham, GSK
  • Phil MacFaul, Sygnature Discovery
  • Pamela Williams, Astex

 Register now

Please note places are limited.

Event sponsored by:

Generon logo Nanotemper Technologies logo 


Sponsorship opportunities are available for this meeting. 
For more details and to find out how you can get involved, please contact Hannah Atkins, Sponsorship Manager.

Biochemical Society Bursaries

We offer a wide variety of grants and bursaries to help you attend this event and save money on registration fees! Support is available to cover registration, accessibility, companion costs and more.

Apply during the registration process for any of the following schemes:

Not a member of the Biochemical Society? Join today and save up to £100 on your registration fee.